newsfilter
← Latest News
GlobeNewswire·

Cabaletta Bio to Participate in Upcoming Investor Conferences in September

PHILADELPHIA, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (NASDAQ:CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed